Organon Announces Agreement to Divest its JADA® System for Up to $465 Million to Laborie
Net proceeds will be applied to debt reduction, advancing Organon's ongoing deleveraging efforts Positions Organon for future investment in growth opportunities with a focus on women's health biopharma and other strategic priorities Laborie's capabilities in
(Financial Post, 2025-11-07T12:33:52Z)